Minhee Kang, Ph.D.
Affiliations: | 2003 | Harvard University, Cambridge, MA, United States |
Area:
Biostatistics BiologyGoogle:
"Minhee Kang"Parents
Sign in to add mentor| Stephen W. Lagakos | grad student | 2003 | Harvard | |
| (Discrete -state, continuous -time stochastic processes, with applications to HPV.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sherman KE, Rouster SD, Kang M, et al. (2018) PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals. Digestive Diseases and Sciences |
| Cespedes MS, Kang M, Kojic EM, et al. (2018) Anogenital Human Papillomavirus Virus DNA and Sustained Response to the Quadrivalent HPV Vaccine in Women Living with HIV-1. Papillomavirus Research (Amsterdam, Netherlands) |
| Wyles DL, Kang M, Matining RM, et al. (2018) Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS). Open Forum Infectious Diseases. 5: ofy103 |
| Hosseinipour MC, Kang M, Krown SE, et al. (2018) As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Shive CL, Judge CJ, Clagett B, et al. (2017) Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine |
| Tam E, Luetkemeyer AF, Mantry PS, et al. (2017) Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naive patients: findings from two randomized trials. Liver International : Official Journal of the International Association For the Study of the Liver |
| Sherman KE, Kang M, Sterling R, et al. (2017) Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World Journal of Hepatology. 9: 217-223 |
| Judge CJ, Sandberg JK, Funderburg NT, et al. (2016) CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. Journal of Acquired Immune Deficiency Syndromes (1999) |
| Petersen T, Lee YJ, Osinusi A, et al. (2016) Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin. Aids Research and Human Retroviruses |
| Jacobson J, Bosinger S, Kang M, et al. (2016) The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. Aids Research and Human Retroviruses |